CORRECTION Algae-C Acquisition by Rockcliffe Labs
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today issues…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
Social Leverage backs LEA’s mission to eliminate manual document work and quickly…
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program…
Manulife Appoints Mike Coyne General Counsel
TORONTO, Aug. 21, 2025 /PRNewswire/ --Â Manulife announced the appointment of Mike Coyne…
Rumble Reports Second Quarter 2025 Results
~ Revenue up 12% Year-over-Year to $25.1 Million ~ ~ Quarter Concluded…
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ --Â In a significant development in…
Asian Nations Dominate Passport Power Ranking as US and UK Continue to Decline
LONDON, July 22, 2025 /PRNewswire/ -- Singapore holds the crown as the…
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired…
NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET Â | Source: NKGen Biotech, Inc. SANTA ANA,…